As of January 22, 2025, Avita Medical (RCEL) has a market cap of $0.22 billion USD. According to our data, Avita Medical is ranked No.7010 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.22 B |
-33.67%
|
Dec 31, 2024 | $0.34 B |
-6.71%
|
Dec 29, 2023 | $0.36 B |
107.88%
|
Dec 30, 2022 | $0.17 B |
-44.91%
|
Dec 31, 2021 | $0.31 B |
-35.52%
|
Dec 31, 2020 | $0.49 B |
-59.16%
|
Dec 31, 2019 | $1.19 B |
712.50%
|
Dec 31, 2018 | $0.15 B |
4.67%
|
Dec 29, 2017 | $0.14 B |
-41.85%
|
Dec 30, 2016 | $0.24 B |
24.32%
|
Dec 31, 2015 | $0.19 B |
19.35%
|
Dec 31, 2014 | $0.16 B |
-51.56%
|
Dec 31, 2013 | $0.34 B |
2.40%
|
Dec 31, 2012 | $0.33 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Integra LifeSciences
IART
|
$1.92 B |
-0.000 M
|
USA
|
Organogenesis
ORGO
|
$0.44 B |
0.000 M
|
USA
|
MiMedx Group
MDXG
|
$1.32 B |
-0.000 M
|
USA
|
Vericel
VCEL
|
$2.89 B |
0.000 M
|
USA
|
Smith & Nephew
SNN
|
$11.00 B |
0.000 M
|
UK
|
Axogen
AXGN
|
$0.83 B |
-0.000 M
|
USA
|
Market Cap | = | RCEL Stock Price | * | RCEL Shares Outstanding |
= | $8.49 | * | 26.22 M | |
= | $0.22 B |